10.1111/j.1749-6632.2000.tb06651.x Ann NY Acad Sci
[PubMed] [PMC] Lyu J, Okada H, Sunagozaka H, Kawaguchi K, Shimakami T, Nio K, Murai K, Shirasaki T, Yoshida M, Arai K, Yamashita T, Tanaka T, Harada K, Takamura T, Kaneko S, Yamashita T, Honda M (2024) Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis
It is specifically for individuals with a starting body mass index (BMI) of 30 kg/m2 or higher (classified as obese) or 27 kg/m2 or higher (classified as overweight) with at least one weight-related medical condition, such as heart disease, elevated cholesterol, high blood pressure, type 2 diabetes, or sleep apnea
Use of a free radical method to evaluate antioxidant activity
GLP-1 is generally well-tolerated, but it can cause some side effects, such as nausea, vomiting, and diarrhea